1. Home
  2. STKH vs GTBP Comparison

STKH vs GTBP Comparison

Compare STKH & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STKH
  • GTBP
  • Stock Information
  • Founded
  • STKH 2018
  • GTBP 1965
  • Country
  • STKH Israel
  • GTBP United States
  • Employees
  • STKH N/A
  • GTBP N/A
  • Industry
  • STKH Packaged Foods
  • GTBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • STKH Consumer Staples
  • GTBP Health Care
  • Exchange
  • STKH Nasdaq
  • GTBP Nasdaq
  • Market Cap
  • STKH 4.9M
  • GTBP 5.5M
  • IPO Year
  • STKH 2021
  • GTBP N/A
  • Fundamental
  • Price
  • STKH $0.71
  • GTBP $2.28
  • Analyst Decision
  • STKH
  • GTBP Strong Buy
  • Analyst Count
  • STKH 0
  • GTBP 1
  • Target Price
  • STKH N/A
  • GTBP $11.00
  • AVG Volume (30 Days)
  • STKH 44.2K
  • GTBP 14.2K
  • Earning Date
  • STKH 03-31-2025
  • GTBP 05-14-2025
  • Dividend Yield
  • STKH N/A
  • GTBP N/A
  • EPS Growth
  • STKH N/A
  • GTBP N/A
  • EPS
  • STKH N/A
  • GTBP N/A
  • Revenue
  • STKH $10,000.00
  • GTBP N/A
  • Revenue This Year
  • STKH N/A
  • GTBP N/A
  • Revenue Next Year
  • STKH N/A
  • GTBP N/A
  • P/E Ratio
  • STKH N/A
  • GTBP N/A
  • Revenue Growth
  • STKH N/A
  • GTBP N/A
  • 52 Week Low
  • STKH $0.60
  • GTBP $1.72
  • 52 Week High
  • STKH $4.64
  • GTBP $10.66
  • Technical
  • Relative Strength Index (RSI)
  • STKH 35.38
  • GTBP 49.46
  • Support Level
  • STKH $0.60
  • GTBP $2.15
  • Resistance Level
  • STKH $0.78
  • GTBP $2.38
  • Average True Range (ATR)
  • STKH 0.13
  • GTBP 0.16
  • MACD
  • STKH 0.01
  • GTBP -0.00
  • Stochastic Oscillator
  • STKH 29.71
  • GTBP 38.24

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is engaged in transforming the alternative protein industries through its technology. The group specializes in developing and selling 3D-printing production machines, supported by proprietary premix blends, formulated from the highest-quality raw ingredients. These tools help manufacturers of all sizes efficiently produce foods that meet consumer expectations for taste, texture, and appearance and offer a safe and sustainable alternative to industrialized meat and seafood production. The company's expertise in creating alternative protein products replicating traditional meats' complex textures such as beef steaks, white fish, shrimp, and eel. It also explores the integration of cultivated cells, preparing for future advancements in food technology.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: